Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomitantly for Pre-exposure Prophylaxis Among Transgender Women

NCT04590417 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Drug Interaction

Interventions

DRUG: Estradiol valerate 2 mg, cyproterone acetate 25 mg

Sponsor

Thai Red Cross AIDS Research Centre